Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jia'nan Cheng
Gene Expression Profiling Identified TP53MutPIK3CAWild as a Potential Biomarker for Patients With Triple‑negative Breast Cancer Treated With Immune Checkpoint Inhibitors
Oncology Letters
Cancer Research
Oncology
Related publications
Risk of Myocarditis in Patients With Cancer Treated With Immune Checkpoint Inhibitors
Chronicles of Oncology
Immune-Related Adverse Effects and Outcome of Patients With Cancer Treated With Immune Checkpoint Inhibitors
Anticancer Research
Medicine
Cancer Research
Oncology
Where Do the Immune Checkpoint Inhibitors Stand in the Management of Triple Negative Breast Cancer?
Immunotherapy
Oncology
Allergy
Immunology
PIM-1 Kinase: A Potential Biomarker of Triple-Negative Breast Cancer
OncoTargets and Therapy
Oncology
Pharmacology
Recurrent Pneumonitis in Patients With Melanoma Treated With Immune Checkpoint Inhibitors
Oncologist
Cancer Research
Medicine
Oncology
Palliative Radiotherapy in Advanced Cancer Patients Treated With Immune‑checkpoint Inhibitors: The PRACTICE Study
Biomedical Reports
Genetics
Pharmacology
Molecular Biology
Biochemistry
Neuroscience
Medicine
Toxicology
Pharmaceutics
Prognostic Genes of Triple‑negative Breast Cancer Identified by Weighted Gene Co‑expression Network Analysis
Oncology Letters
Cancer Research
Oncology
Checkpoint Inhibitors in Triple-Negative Breast Cancer (TNBC): Where to Go From Here
Cancer
Cancer Research
Oncology
Prognostic Value of ERBB4 Expression in Patients With Triple Negative Breast Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
